The claimed method relates to a method for reducing blood loss. More specifically, the claimed method utilizes at least one compound deposited within and/or on a medical applicator to reduce blood loss experienced by a user. In some embodiments, the method may include depositing at least one compound onto or within a medical applicator which promotes diminished blood flow and coagulation when the applicator is used. More specifically, the medical applicator may have a compound adhered to the surface which acts as a catalyst to instigate blood clotting when the medical applicator is used for its intended purpose. In some embodiments, an antifibrinolytic may be deposited onto the medical applicator. In other embodiments, compounds causing vasoconstriction may be deposited onto the medical applicator. In yet other embodiments, a plurality of compounds may be deposited within and/or on the surface of the medical applicator.
